US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist
  • 2.530
  • -0.060-2.32%
Close Mar 28 16:00 ET
  • 2.550
  • +0.020+0.79%
Post 19:56 ET
132.07MMarket Cap-170P/E (TTM)

About Emergent BioSolutions Company

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Company Profile

SymbolEBS
Company NameEmergent BioSolutions
Listing Date10/02/2009
Issue Price12.50
Founded1998
CEOMr. Joseph C. Papa
MarketNYSE
Employees1600
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address300 Professional Drive,Suite 400
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20879
Phone1-240-631-3200

Company Executives

  • Name
  • Position
  • Salary
  • Joseph C. Papa
  • Director, President and Chief Executive Officer
  • --
  • Richard S. Lindahl
  • Principal Accounting Officer, Executive Vice President, Chief Financial Officer and Treasurer
  • 3.52M
  • Michelle Pepin
  • Senior Vice President and Chief Human Resource Officer
  • --
  • Jennifer Fox
  • Executive Vice President, External Affairs, General Counsel and Secretary
  • 2.92M
  • Coleen Glessner
  • Executive Vice President, Quality and Ethics and Compliance
  • --
  • Paul Williams
  • Senior Vice President, Products Business
  • --
  • Kelly Warfield
  • Senior Vice President, Science and Development
  • --
  • Bill Hartzel
  • Senior Vice President and Head of Bioservices
  • --
  • Dr. Zsolt Harsanyi,PhD
  • Chairman of The Board
  • 512.50K
  • Sujata Dayal
  • Director
  • 416.58K
  • General George A. Joulwan
  • Independent Director
  • 390.00K
  • Keith A. Katkin
  • Independent Director
  • 446.25K
  • Dr. Louis W. Sullivan, M.D.
  • Independent Director
  • 410.00K
  • Ronald B. Richard
  • Independent Director
  • 412.50K
  • Neal F. Fowler
  • Independent Director
  • --
  • Marvin L. White
  • Independent Director
  • 398.75K
  • Donald W. DeGolyer
  • Independent Director
  • --
  • Dr. Kathryn C. Zoon
  • Independent Director
  • 427.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg